233365 US DHHS Secretary's Strategic Initiative to Prevent and Reduce Tobacco Use

Monday, November 8, 2010 : 3:50 PM - 4:10 PM

Ursula Bauer, PhD, MPH , National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA
Pebbles Fagan, PhD, MPH , Tobacco Control Research Branch, BRP, DCCPS, National Cancer Institute, Bethesda, MD
Michael Fiore, MD, MPH, MBA , Center for Tobacco Research and Intervention, University of Wisconsin Medical School, Madison, WI
Kyu Rhee, MD, MPP, FAAP, FACP , Health Resources and Services Administration, U.S. Department of Health and Human Services, Rockville, MD
The National Cancer Institute (NCI) has recently approved a major new tobacco control initiative on State and Community Tobacco Control Policy and Media Research to support innovative research in this area. This is the largest tobacco control research program currently supported by the federal government and has tremendous potential to inform the field of public health practice and shape future policy development and tobacco use prevention media efforts. This research will identify responses to critical unanswered questions regarding key topics in tobacco control policy and media with the goal of informing tobacco control programs and policies at the state and community level across the U.S. and beyond. Topics include exposure to secondhand smoke in homes, cars, multi-unit housing or casinos; tobacco pricing policies and industry attempts to circumvent tax increases; use of new media strategies, tools or campaigns to reduce tobacco use; or ways the tobacco industry has interfered with public health approaches to tobacco control. These cooperative agreements reflect the most cutting-edge research available on these topics by outstanding scientists in the field. This session will include presentations by some of the NCI grantees participating in this initiative who will explain the focus of their research and current plans to proactively disseminate findings, as well as a discussion of how the field can contribute to the research being conducted and disseminated to ensure maximum public health impact by preventing and reducing all forms of tobacco use and exposure to secondhand smoke.

Learning Areas:
Administration, management, leadership
Advocacy for health and health education
Communication and informatics
Planning of health education strategies, interventions, and programs
Public health or related research
Social and behavioral sciences

Learning Objectives:
Describe evidence-based tobacco control interventions Discuss agenda to promote a cultural change around tobacco use Describe new research and surveillance activities for tobacco use prevention and control

Keywords: Tobacco Control, Evidence Based Practice

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: Ursula Bauer, PhD, MPH, is the director of CDC’s National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), a position she assumed on January 4, 2010. In that role, she sets the strategic direction for the center’s “Winnable Battles” of tobacco use prevention, improved nutrition and physical activity, and prevention of teen and unintended pregnancy, as well as key priorities related to the leading causes of death. NCCDPHP has an annual budget of about $1 billion and 1,300 staff dedicated to preventing chronic diseases and promoting health across the life span, in key settings, and with attention to the primary chronic disease risk factors. Before becoming director of NCCDPHP, Dr. Bauer was director of the Division of Chronic Disease and Injury Prevention in the New York State Department of Health. Her entire public health career has been in state service, in Louisiana, Florida, and New York. Dr. Bauer received her PhD in epidemiology from Yale University, her MPH in family health from Columbia University, and a master’s degree in political science from Rutgers University.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.